Dr. Jeff Healey and Professor Pier Lambiase discuss the results of the ATLAS trial, evaluating and comparing the lead related complications between TV-ICD and EMBLEM S-ICD patients, and key secondary endpoints including inappropriate shocks.
Login to view comments.
Click here to Login
